Multi-target license agreement grants Sidewinder access to Lonza's clinically validated ADC platformSidewinder's pipeline of precision bispecific ADCs combined with Lonza's clinically validated ...

Epithelioma Treatment Market to reach USD 13.1 billion by 2035, driven by rising skin cancer cases and growing adoption of ...

Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line1 ...

The trial aims to establish clinical proof-of-concept in psoriasis and proof-of-mechanism for other CCR6- and Th17-associated autoimmune indications Allschwil, Switzerland - January 6, 2026Idorsia ...

The trial aims to establish clinical proof-of-concept in psoriasis and proof-of-mechanism for other CCR6- and Th17-associated autoimmune indicationsAllschwil, Switzerland - January 6, 2026 ...

GSK has received approval from China’s National Medical Products Administration for Nucala as an add-on maintenance therapy for adults with inadequately controlled COPD and elevated blood eosinophils.

Life begins with a single fertilized cell that gradually transforms into a multicellular organism. This process requires ...

The Central Board of Secondary Education (CBSE) has officially released the final date sheet for the Class 10 Board ...

A newly recognized set of T helper cells seems to guard against aging by eliminating harmful senescent cells. Their presence in supercentenarians suggests they may be a key to maintaining a healthier, ...

This is read by an automated voice. Please report any issues or inconsistencies here. In July, 9-year-old Stephen Mondek became what Cedars-Sinai Medical Center believes is its youngest known stem ...

SpaceX and the company behind Boost Mobile have struck a deal that will bolster Starlink’s direct-to-cell satellite mobile service. EchoStar has agreed to license AWS-4 and H-block spectrum to SpaceX.